FDA clears AstraZeneca, Merck drug to treat some genetic breast cancers early

[cafead]

via The Food and Drug Administration has approved AstraZeneca and Merck & Co.'s drug Lynparza for people with a genetic form of early breast cancer, a decision that could spur greater use of DNA testing in diagnosing and treating the disease.

article source